Skin toxicities of targeted therapies

Eur J Cancer. 2009 Sep;45 Suppl 1:295-308. doi: 10.1016/S0959-8049(09)70044-9.
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Clinical Trials as Topic
  • Disease Progression
  • Disease-Free Survival
  • Drug Eruptions / classification
  • Drug Eruptions / etiology*
  • Drug Eruptions / therapy
  • Enzyme Inhibitors / adverse effects
  • ErbB Receptors / antagonists & inhibitors*
  • Humans
  • Neoplasms / drug therapy*
  • Phosphotransferases / antagonists & inhibitors
  • Telangiectasis / chemically induced
  • Terminology as Topic
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Phosphotransferases
  • ErbB Receptors